|Articles|March 1, 2010
- BioPharm International-03-01-2010
- Volume 23
- Issue 3
BioPharm International, March 2010 Issue (PDF)
Best Practices for Characterizing Formulation Design
Advertisement
Articles in this issue
almost 16 years ago
India's Future as a Biologics Manufacturing Hubalmost 16 years ago
Downstream Processing: Promising Technologies are on the Horizonalmost 16 years ago
Corrective and Preventative Action Programs: A Mechanism of Controlalmost 16 years ago
Characterizing the Formulation Design Spacealmost 16 years ago
FDA Seeks More Timely Drug Information Electronicallyalmost 16 years ago
Quality Considerations for Peptide Manufacturing Processesalmost 16 years ago
Lessons from the War on TerrorismNewsletter
Stay at the forefront of biopharmaceutical innovation—subscribe to BioPharm International for expert insights on drug development, manufacturing, compliance, and more.
Advertisement
Advertisement
Advertisement
Trending on BioPharm International
1
FDA-Approved WAS Gene Therapy Hits Market in Nonprofit Model
2
Two-Minute Mysteries: BioPharm Stories - Episode 2: The Costly Myth of Noninvasive Glucose Monitoring
3
Developing Next-Gen Cell Lines Using Targeted Integration
4
FAQ: Shifts in FDA Regulations and Strategies in 2025
5
